Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
23.50%
↑ 1538% vs avg
Percentile
P100
Near historical high
Streak
3 qtr
Consecutive growthAccelerating
Average
-1.63%
Historical baseline
PeriodValue
Q4 202523.50%
Q3 202517.63%
Q2 2025-18.11%
Q1 2025-38.32%
Q4 2024-25.69%
Q3 202417.26%
Q2 20246.32%
Q1 2024-33.53%
Q4 2023-3.51%
Q3 202311.49%
Q2 202323.35%
Q1 20230.00%